Ben Price
Director/Board Member at PERCHERON THERAPEUTICS LIMITED
Net worth: 54 139 $ as of 2024-03-30
Profile
Ben Gil Price is currently an Independent Non-Executive Director at Percheron Therapeutics Ltd., a Director at AssayQuant Technologies, Inc., and the Chief Medical Officer at KCBN Holding, Inc. He previously worked as a Clinical Development Director-Oncology at MedImmune LLC from 1997 to 2002, an Independent Director at Sarepta Therapeutics, Inc. from 2007 to 2016, a Director at Rexahn Pharmaceuticals, Inc. from 2018 to 2020, and as the Chief Executive & Medical Officer at Drug Safety Solutions LLC from 2002 to 2017.
He is also a Member of the American Medical Association, the Academy of Physicians In Clinical Research, and the American Society for Microbiology.
Dr. Price holds an undergraduate degree from the University of Rio Grande and graduate and doctorate degrees from the University of Santiago de Compostela.
He is currently serving as the President, Chief Executive & Medical Officer at NeuroBo Pharmaceuticals, Inc. until 2023.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-25 | 999,805 ( 0.11% ) | 54 139 $ | 2024-03-30 |
Ben Price active positions
| Companies | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Director/Board Member | 2021-10-03 |
KCBN Holding, Inc.
 KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| Assayquant Technologies, Inc. | Director/Board Member | - |
Former positions of Ben Price
| Companies | Position | End |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Chief Executive Officer | 2023-01-11 |
| REXAHN PHARMACEUTICALS, INC. | Director/Board Member | 2020-10-31 |
| Drug Safety Solutions LLC | Chief Executive Officer | 2017-06-30 |
| SAREPTA THERAPEUTICS, INC. | Director/Board Member | 2015-12-31 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2001-12-31 |
Training of Ben Price
| University of Rio Grande | Undergraduate Degree |
| University of Santiago de Compostela | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Commercial Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Academy of Physicians In Clinical Research | |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Commercial Services |
| Drug Safety Solutions LLC | |
KCBN Holding, Inc.
KCBN Holding, Inc. MiscellaneousMiscellaneous KCBN Holding, Inc. provides compliance services to the healthcare sector. The company is headquartered in Kansas City, MO. | Miscellaneous |
| Assayquant Technologies, Inc. |
- Stock Market
- Insiders
- Ben Price
